1. Rosen CA, Lee AS, Osborne J, Zullo T, Murry T: Development and Validation of the Voice Handicap Index-10: The Laryngoscope 2004, 114:1549–1556.
2. Cohen SM, Dupont WD, Courey MS: Quality-of-Life Impact of Non-Neoplastic Voice Disorders: A Meta-Analysis. Ann Otol Rhinol Laryngol 2006, 115:128–134.
3. Woo P, Casper J, Colton R, Brewer D: Diagnosis and treatment of persistent dysphonia after laryngeal surgery: A retrospective analysis of 62 patients. The Laryngoscope 1994, 104:1084–1091.
4. Hirano S, Minamiguchi S, Yamashita M, Ohno T, Kanemaru S, Kitamura M: Histologic Characterization of Human Scarred Vocal Folds. J Voice 2009, 23:399–407.
5. Welham NV, Montequin DW, Tateya I, Tateya T, Choi SH, Bless DM: A Rat Excised Larynx Model of Vocal Fold Scar. J Speech Lang Hear Res 2009, 52:1008–1020.
6. Hansen JK, Thibeault SL: Current Understanding and Review of the Literature: Vocal Fold Scarring. J Voice 2006, 20:110–120.
7. Kishimoto Y, Kishimoto AO, Ye S, Kendziorski C, Welham NV: Modeling fibrosis using fibroblasts isolated from scarred rat vocal folds. Lab Invest 2016, 96:807–816.
8. Hirano S, Bless D, Heisey D, Ford C: Roles of hepatocyte growth factor and transforming growth factor beta1 in production of extracellular matrix by canine vocal fold fibroblasts. The Laryngoscope 2003, 113:144–148.
9. Suehiro A, Hirano S, Kishimoto Y, Tateya I, Rousseau B, Ito J: Effects of Basic Fibroblast Growth Factor on Rat Vocal Fold Fibroblasts. Ann Otol Rhinol Laryngol 2010, 119:690–696.
10. Chang Z, Kishimoto Y, Hasan A, Welham NV: TGF- 3 modulates the inflammatory environment and reduces scar formation following vocal fold mucosal injury in rats. Dis Model Mech 2014, 7:83–91.
11. Hiwatashi N, Bing R, Kraja I, Branski RC: Mesenchymal stem cells have antifibrotic effects on transforming growth factor-β1-stimulated vocal fold fibroblasts: MSCs Antifibrotic Effects on TGF- β1-Stimulated VFFs. The Laryngoscope 2017, 127:E35–E41.
12. Hirano S, Bless DM, Rousseau B, Welham N, Montequin D, Chan RW, Ford CN: Prevention of Vocal Fold Scarring by Topical Injection of Hepatocyte Growth Factor in a Rabbit Model: The Laryngoscope 2004, 114:548–556.
13. Suzuki R, Kawai Y, Tsuji T, Hiwatashi N, Kishimoto Y, Tateya I, Nakamura T, Hirano S: Prevention of vocal fold scarring by local application of basic fibroblast growth factor in a rat vocal fold injury model: Prevention of Vocal Fold Scarring by bFGF. The Laryngoscope 2017, 127:E67–E74.
14. Svensson B, Nagubothu RS, Cedervall J, Le Blanc K, Ährlund-Richter L, Tolf A, Hertegård S: Injection of human mesenchymal stem cells improves healing of scarred vocal folds: Analysis using a xenograft model. The Laryngoscope 2010, 120:1370–1375.
15. Henderson NC, Rieder F, Wynn TA: Fibrosis: from mechanisms to medicines. Nature 2020, 587:555– 566.
16. Wynn TA, Vannella KM: Macrophages in Tissue Repair, Regeneration, and Fibrosis. Immunity 2016, 44:450–462.
17. Vannella KM, Wynn TA: Mechanisms of Organ Injury and Repair by Macrophages. In: Julius D, editor. Annu Rev Physiol Vol 79, Palo Alto, Annual Reviews, 2017, pp. 593–617.
18. Varga T, Mounier R, Horvath A, Cuvellier S, Dumont F, Poliska S, Ardjoune H, Juban G, Nagy L, Chazaud B: Highly Dynamic Transcriptional Signature of Distinct Macrophage Subsets during Sterile Inflammation, Resolution, and Tissue Repair. J Immunol 2016, 196:4771–4782.
19. King SN, Chen F, Jetté ME, Thibeault SL: Vocal fold fibroblasts immunoregulate activated macrophage phenotype. Cytokine 2013, 61:228–236.
20. King SN, Hanson SE, Chen X, Kim J, Hematti P, Thibeault SL: In vitro characterization of macrophage interaction with mesenchymal stromal cell-hyaluronan hydrogel constructs: Macrophage Interaction with MSC-Hydrogel Constructs. J Biomed Mater Res A 2014, 102:890–902.
21. Hanson SE, King SN, Kim J, Chen X, Thibeault SL, Hematti P: The Effect of Mesenchymal Stromal Cell–Hyaluronic Acid Hydrogel Constructs on Immunophenotype of Macrophages. Tissue Eng Part A 2011, 17:2463–2471.
22. Chen H, Shi R, Luo B, Yang X, Qiu L, Xiong J, Jiang M, Liu Y, Zhang Z, Wu Y: Macrophage peroxisome proliferator-activated receptor γ deficiency delays skin wound healing through impairing apoptotic cell clearance in mice. Cell Death Dis 2015, 6:e1597–e1597.
23. Lawrence T, Natoli G: Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 2011, 11:750–761.
24. Tokutome M, Matoba T, Nakano Y, Okahara A, Fujiwara M, Koga J-I, Nakano K, Tsutsui H, Egashira K: Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models. Cardiovasc Res 2019, 115:419–431.
25. Lefere S, Puengel T, Hundertmark J, Penners C, Frank AK, Guillot A, de Muynck K, Heymann F, Adarbes V, Defrêne E, Estivalet C, Geerts A, Devisscher L, Wettstein G, Tacke F: Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages. J Hepatol 2020, 73:757–770.
26. Tateya T, Sohn JH, Tateya I, Bless DM: Histologic Characterization of Rat Vocal Fold Scarring. Ann Otol Rhinol Laryngol 2005, 114:183–191.
27. Ling C, Yamashita M, Waselchuk EA, Raasch JL, Bless DM, Welham NV: Alteration in cellular morphology, density and distribution in rat vocal fold mucosa following injury. Wound Repair Regen
28. Yamashita M, Bless DM, Welham NV: Surgical Method to Create Vocal Fold Injuries in Mice. Ann Otol Rhinol Laryngol 2009, 118:131–138.
29. Hiwatashi N, Hirano S, Mizuta M, Tateya I, Kanemaru S, Nakamura T, Ito J: Adipose-derived stem cells versus bone marrow-derived stem cells for vocal fold regeneration: Comparison of ASC and BMSC. The Laryngoscope 2014, 124:E461–E469.
30. Tateya I, Tateya T, Lim X, Sohn JH, Bless DM: Cell Production in Injured Vocal Folds: A Rat Study. Ann Otol Rhinol Laryngol 2006, 115:135–143.
31. Zhu M, Li W, Dong X, Yuan X, Midgley AC, Chang H, Wang Y, Wang H, Wang K, Ma PX, Wang H, Kong D: In vivo engineered extracellular matrix scaffolds with instructive niches for oriented tissue regeneration. Nat Commun 2019, 10:4620.
32. Venosa A, Malaviya R, Choi H, Gow AJ, Laskin JD, Laskin DL: Characterization of Distinct Macrophage Subpopulations during Nitrogen Mustard–Induced Lung Injury and Fibrosis. Am J Respir Cell Mol Biol 2016, 54:436–446.
33. Mizuta M, Hirano S, Hiwatashi N, Tateya I, Kanemaru S, Nakamura T, Ito J: Effect of astaxanthin on vocal fold wound healing. The Laryngoscope 2014, 124:E1–E7.
34. Chang Z, Ling C, Yamashita M, Welham NV: Microarray-driven validation of reference genes for quantitative real-time polymerase chain reaction in a rat vocal fold model of mucosal injury. Anal Biochem 2010, 406:214–221.
35. Livak KJ, Schmittgen TD: Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods 2001, 25:402–408.
36. Chanput W, Mes JJ, Savelkoul HFJ, Wichers HJ: Characterization of polarized THP-1 macrophages and polarizing ability of LPS and food compounds. Food Funct 2013, 4:266–276.
37. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP: Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005, 115:56–65.
38. Gibbons MA, MacKinnon AC, Ramachandran P, Dhaliwal K, Duffin R, Phythian-Adams AT, van Rooijen N, Haslett C, Howie SE, Simpson AJ, Hirani N, Gauldie J, Iredale JP, Sethi T, Forbes SJ: Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am J Respir Crit Care Med 2011, 184:569–581.
39. Lin SL, Castaño AP, Nowlin BT, Lupher ML, Duffield JS: Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 2009, 183:6733–6743.
40. Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Müller W, Roers A, Eming SA: Differential Roles of Macrophages in Diverse Phases of Skin Repair. J Immunol 2010, 184:3964–3977.
41. Mirza R, DiPietro LA, Koh TJ: Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 2009, 175:2454–2462.
42. Kaba S, Nakamura R, Yamashita M, Katsuno T, Suzuki R, Tateya I, Kishimoto Y, Omori K: Alterations in macrophage polarization in injured murine vocal folds. The Laryngoscope 2019, 129:E135–E142.
43. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677–686.
44. Kume O, Takahashi N, Wakisaka O, Nagano-Torigoe Y, Teshima Y, Nakagawa M, Yufu K, Hara M, Saikawa T, Yoshimatsu H: Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats. Heart Rhythm 2011, 8:278–285.
45. Dasu MR, Park S, Devaraj S, Jialal I: Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice. Endocrinology 2009, 150:3457–3464.
46. Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T: Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem 1997, 272:31092–31099.
47. Hildebrand DG, Alexander E, Hörber S, Lehle S, Obermayer K, Münck N-A, Rothfuss O, Frick J-S, Morimatsu M, Schmitz I, Roth J, Ehrchen JM, Essmann F, Schulze-Osthoff K: IκBζ Is a Transcriptional Key Regulator of CCL2/MCP-1. J Immunol 2013, 190:4812–4820.
48. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK: The peroxisome proliferator-activated receptor- gamma is a negative regulator of macrophage activation. Nature 1998, 391:79–82.
49. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG, Glass CK: A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 2005, 437:759–763.
50. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM: PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 2001, 7:48–52.
51. Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, Glass CK: 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci U S A 2000, 97:4844–4849.
52. Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, Glass CK: PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci U S A 2003, 100:6712–6717.
53. Tsou C-L, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP, Mack M, Charo IF: Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007, 117:902–909.
54. Pang J, Maienschein-Cline M, Koh TJ: Enhanced Proliferation of Ly6C+ Monocytes/Macrophages Contributes to Chronic Inflammation in Skin Wounds of Diabetic Mice. J Immunol 2021, 206:621– 630.
55. Menezes S, Melandri D, Anselmi G, Perchet T, Loschko J, Dubrot J, Patel R, Gautier EL, Hugues S, Longhi MP, Henry JY, Quezada SA, Lauvau G, Lennon-Duménil A-M, Gutiérrez-Martínez E, Bessis A, Gomez-Perdiguero E, Jacome-Galarza CE, Garner H, Geissmann F, Golub R, Nussenzweig MC, Guermonprez P: The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells. Immunity 2016, 45:1205–1218.
56. Lavine KJ, Epelman S, Uchida K, Weber KJ, Nichols CG, Schilling JD, Ornitz DM, Randolph GJ, Mann DL: Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc Natl Acad Sci U S A 2014, 111:16029–16034.
57. Misharin AV, Morales-Nebreda L, Reyfman PA, Cuda CM, Walter JM, McQuattie-Pimentel AC, Chen C-I, Anekalla KR, Joshi N, Williams KJN, Abdala-Valencia H, Yacoub TJ, Chi M, Chiu S, Gonzalez- Gonzalez FJ, Gates K, Lam AP, Nicholson TT, Homan PJ, Soberanes S, Dominguez S, Morgan VK, Saber R, Shaffer A, Hinchcliff M, Marshall SA, Bharat A, Berdnikovs S, Bhorade SM, Bartom ET, Morimoto RI, Balch WE, Sznajder JI, Chandel NS, Mutlu GM, Jain M, Gottardi CJ, Singer BD, Ridge KM, Bagheri N, Shilatifard A, Budinger GRS, Perlman H: Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J Exp Med 2017, 214:2387–2404.
58. Sakai N, Wada T, Furuichi K, Shimizu K, Kokubo S, Hara A, Yamahana J, Okumura T, Matsushima K, Yokoyama H, Kaneko S: MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes. J Leukoc Biol 2006, 79:555–563.
59. Vyas B, Ishikawa K, Duflo S, Chen X, Thibeault SL: Inhibitory effects of hepatocyte growth factor and interleukin-6 on transforming growth factor-beta1 mediated vocal fold fibroblast-myofibroblast differentiation. Ann Otol Rhinol Laryngol 2010, 119:350–357.
60. Nakamura R, Mukudai S, Bing R, Garabedian MJ, Branski RC: Complex fibroblast response to glucocorticoids may underlie variability of clinical efficacy in the vocal folds. Sci Rep 2020, 10:20458.
61. Lim X, Bless DM, Muñoz-Del-Río A, Welham NV: Changes in cytokine signaling and extracellular matrix production induced by inflammatory factors in cultured vocal fold fibroblasts. Ann Otol Rhinol Laryngol 2008, 117:227–238.
62. Omori K, Slavit DH, Matos C, Kojima H, Kacker A, Blaugrund SM: Vocal fold atrophy: quantitative glottic measurement and vocal function. Ann Otol Rhinol Laryngol 1997, 106:544–551.
63. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM: mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994, 8:1224–1234.
64. Sandouk T, Reda D, Hofmann C: Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am J Physiol 1993, 264:C1600-1608.
65. Milam JE, Keshamouni VG, Phan SH, Hu B, Gangireddy SR, Hogaboam CM, Standiford TJ, Thannickal VJ, Reddy RC: PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008, 294:L891-901.
66. Ghosh AK, Bhattacharyya S, Lakos G, Chen S-J, Mori Y, Varga J: Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator- activated receptor gamma. Arthritis Rheum 2004, 50:1305–1318.
67. Klotz L, Burgdorf S, Dani I, Saijo K, Flossdorf J, Hucke S, Alferink J, Nowak N, Novak N, Beyer M, Mayer G, Langhans B, Klockgether T, Waisman A, Eberl G, Schultze J, Famulok M, Kolanus W, Glass C, Kurts C, Knolle PA: The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J Exp Med 2009, 206:2079–2089.
68. Law RE, Goetze S, Xi XP, Jackson S, Kawano Y, Demer L, Fishbein MC, Meehan WP, Hsueh WA: Expression and function of PPARgamma in rat and human vascular smooth muscle cells. Circulation 2000, 101:1311–1318.
69. Hucke S, Floßdorf J, Grützke B, Dunay IR, Frenzel K, Jungverdorben J, Linnartz B, Mack M, Peitz M, Brüstle O, Kurts C, Klockgether T, Neumann H, Prinz M, Wiendl H, Knolle P, Klotz L: Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ. Brain J Neurol 2012, 135:1586–1605.
70. Abdullah Z, Geiger S, Nino-Castro A, Böttcher JP, Muraliv E, Gaidt M, Schildberg FA, Riethausen K, Flossdorf J, Krebs W, Chakraborty T, Kurts C, Schultze JL, Knolle PA, Klotz L: Lack of PPARγ in myeloid cells confers resistance to Listeria monocytogenes infection. PloS One 2012, 7:e37349.
71. Morán-Salvador E, Titos E, Rius B, González-Périz A, García-Alonso V, López-Vicario C, Miquel R, Barak Y, Arroyo V, Clària J: Cell-specific PPARγ deficiency establishes anti-inflammatory and anti- fibrogenic properties for this nuclear receptor in non-parenchymal liver cells. J Hepatol 2013, 59:1045–1053.
72. Caglayan E, Stauber B, Collins AR, Lyon CJ, Yin F, Liu J, Rosenkranz S, Erdmann E, Peterson LE, Ross RS, Tangirala RK, Hsueh WA: Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis. Diabetes 2008, 57:2470–2479.
73. Fujita Y, Yamada Y, Kusama M, Yamauchi T, Kamon J, Kadowaki T, Iga T: Sex differences in the pharmacokinetics of pioglitazone in rats. Comp Biochem Physiol Toxicol Pharmacol CBP 2003, 136:85–94.
74. Sato H, Sugai H, Kurosaki H, Ishikawa M, Funaki A, Kimura Y, Ueno K: The effect of sex hormones on peroxisome proliferator-activated receptor gamma expression and activity in mature adipocytes. Biol Pharm Bull 2013, 36:564–573.
75. Kadowaki K, Fukino K, Negishi E, Ueno K: Sex differences in PPARgamma expressions in rat adipose
論文の公開元へ
